In 2014, Voskuhl participated in an interview discussing estriol as a potential treatment for women with MS. The article discussed how estriol was identified as a potential candidate for drug treatment, including an anecdote about Melissa Glasser, a woman who experienced a reduction in her MS symptoms during each of her four pregnancies.[15]